
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Breast malignant, males, children
Carcinoma subtypes
Metaplastic carcinoma - general
Reviewer: Monika Roychowdhury, M.D. (see Reviewers
page)
Revised: 25 September 2012, last major update September 2012
Copyright: (c) 2001-2012, PathologyOutlines.com, Inc.
See also subtypes / variants: fibromatosis-like,, matrix producing, spindle cell
Definition
=========================================================================
● Heterogeneous group of neoplasms with predominant component other than epithelial / glandular
Terminology
=========================================================================
● Also called carcinosarcoma (if mesenchymal component is malignant), carcinoma with osteoclastic giant cells and carcinoma with osseous metaplasia
● “Metaplastic” due to the transformation of epithelial component into a non-glandular component, such as spindle cells, squamous cells or heterologous elements
Clinical features
=========================================================================
● Uncommon (< 5% of breast carcinomas)
● More aggressive than invasive ductal NOS due to larger tumor size, higher grade
● Metastases tend to be hematogenous and not nodal (Ann Surg Oncol 2007;14:166, Breast Cancer Res Treat 2007;101:349)
● Represents a type of basal-like carcinoma lacking epidermal growth factor receptor and KIT activating mutations, but exhibiting high epidermal growth factor receptor copy number, primarily via aneusomy (Mol Cancer Ther 2008;7:944)
Case reports
=========================================================================
● 35 year old woman BRCA1 carrier (Breast Cancer 2011;18:137)
● 37 year old woman with giant cystic tumor (Acta Cytol 2006;50:327)
● 49 year old woman with metaplastic carcinoma of abdominal wall muscle (Breast Cancer 2012 Mar 2 [Epub ahead of print])
● 52 year old woman with CD117+ tumor (The Internet Journal of Pathology 2009;8:2)
● 52 year old woman with ductal, squamous and cartilaginous components in tumor (Mod Pathol 2001;14:1183)
● 57 year old woman with abscess (Int Semin Surg Oncol 2006;3:23)
● 66 year old woman with circumscribed mass (Case of the Week #6)
● 77 year old woman with extensive osseous differentiation (Breast 2008;17:314)
● Bilateral tumors, each clonal but different clones (Hum Pathol 2002;33:677)
● With melanocytic differentiation (Mod Pathol 1997;10:592)
Treatment
=========================================================================
● Mastectomy or local excision
Gross description
=========================================================================
● Well-circumscribed
● Median 3-4 cm, range 1-21 cm
● Usually firm, nodular
● Squamous or chondroid areas are pearly white to gray glistening areas on cut surface
Gross images
=========================================================================
Bisected squamous tumor (arrows at tumor margin)
Carcinoma with osteoclast-like giant cells
Causing skin ulceration
Sharply circumscribed tumor
Micro description
=========================================================================
● Sarcomatous component resembles fibromatosis (see variant), fibrosarcoma, malignant fibrous histiocytoma, chondrosarcoma or osteosarcoma (see variant), rhabdomyosarcoma, spindle cells (see variant), angiosarcoma or combination
● May need to look carefully for epithelial component (may be ductal carcinoma in situ or invasive ductal carcinoma), may have osteoclast-like giant cells (Hum Pathol 1990;21:142)
● Some classify as “with squamous metaplasia” or “with heterologous metaplasia”
● Recommended to test any keratin negative stromal tumor of the breast with myoepithelial markers before calling it a primary sarcoma (Am J Surg Pathol 2005;29:347)
Micro images
=========================================================================
Epithelioid and spindled areas
Various images
With osteoclast-like giant cells Various images
Case of the Week #6 CK7 S100
Left: glandular component; right: glandular and squamous components
Left: squamous differentiation; right: ductal, squamous and cartilaginous components
Invasion patterns: left-irregular; right-DFSP like
Fibrosarcoma-like pattern
Angiomatoid pattern Keratin+
Osteosarcoma-like Low-grade spindle cell metaplastic carcinoma arising within papilloma
Nodal metastases
Keratin+ cells Epithelium is keratin+, stroma is keratin-
H&E, EGFR and EGFR EGFR and HER2 overexpression
EGFR-CISH in spindle cell carcinoma
Malignant squamous component Storiform squamous type
Various images
AFIP images:
Well differentiated epidermoid carcinoma Adenocarcinoma with a tubular pattern
and poorly differentiated adenocarcinoma in the metaplastic spindle cell component
merge with the spindle cell component
Carcinomatous glands are surrounded by an Transition from adenocarcinoma
undifferentiated round cell proliferation to spindle cell pattern
that merges with the spindle cells
Poorly differentiated carcinoma with traces Invasive adenocarcinoma at upper right, but most
of squamous metaplasia giving rise to the tumor is solid pseudosarcomatous metaplastic
spindle cell component elements with pale, serpiginous areas of necrosis
Adenocarcinoma with transition to Recurrent metaplastic carcinoma 4 years
undifferentiated carcinoma, an intermediate after mastectomy, tumor was initially
step in conversion to spindle cell metaplasia interpreted as a radiation induced sarcoma
Osteoclast-like giant cells in stroma Resembles giant cell tumor of bone
associated with the carcinoma component due to osteoclast-like giant cells
Cytology description
=========================================================================
● Moderate / high cellularity (68%), necrosis (47%), cells are sarcomatoid, poorly differentiated carcinoma or squamous carcinoma
● Dual components usually not identified (J Clin Pathol 2007;60:529)
● Also clusters of carcinoma cells (Diagn Cytopathol 2006;34:772)
Virtual slides
=========================================================================
Left: two tumors; right: with myoepithelial and myxoid components
Positive stains
=========================================================================
● Vimentin in mesenchymal elements
● Keratin (broad spectrum or 34betaE12) in spindle or epithelial cells
● EGFR (76%, Breast Cancer Res 2005;7:R1028)
● Squamous components are p63+
● Non-squamous tumors express smooth muscle actin and p63 (nuclear staining, Am J Surg Pathol 2004;28:1506)
● Chondroid cells are S100+
● Also laminin 5 (Am J Surg Pathol 2008;32:345), CD10, CD29 and 14-3-3-sigma (Am J Surg Pathol 2005;29:347)
● Variably positive for CK5 and CK14 (Hum Pathol 2003;34:1009)
Negative stains
=========================================================================
● ER, PR, HER2 (Turk Patoloji Derg 2012;28:134) and mucin
● Often S100
● Mammaglobin (Am J Clin Pathol 2012;137:747)
Molecular description
=========================================================================
● Epithelial and sarcoma components originate from same clone
● Epidermal growth factor receptor overexpression in 2/3, 1/3 of these have EGFR gene amplification, but no activating EGFR mutations (J Pathol 2006;209:445)
Differential diagnosis
=========================================================================
● Myoepithelial carcinoma: may have ducts with prominent myoepithelial cells at periphery, diffusely S100+
● Myofibroblastic tumors
● Phyllodes tumor
● Primary breast sarcoma: no epithelial elements or keratin+ elements
Additional references
=========================================================================
● Am J Surg Pathol 1998;22:188, Am J Surg Pathol 1987;11:918, Stanford University
● J Clin Imaging Sci 2012;2:21, J BUON 2011;16:652, Tumori 2011;97:e1
End of Breast malignant, males, children > Carcinoma subtypes > Metaplastic carcinoma - general
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other
contact information).